proxyvotesnow.com
23,338,039
Vote Records
27,979
Companies
11,817
Funds
4,051
Managers

Home › Companies › Sanara MedTech Inc. › 2025-2026

Sanara MedTech Inc. 2025-2026 Proxy Voting Records

At Sanara MedTech Inc.'s shareholder meeting held June 4, 2026, in the 2025-2026 proxy season, 88 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,096 separate fund positions. Their filings are grouped here into 12 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS… — FOR was 99% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Sanara MedTech Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 9, 2026.

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and Sanara MedTech Inc.’s Form 8-K, filed June 9, 2026 (Item 5.07 on EDGAR). Page generated November 8, 2026.

  • 12Reported items
  • 88Asset managers
  • 1,096Fund votes
  • June 4, 2026Meeting date

Results at a glance

Meeting of June 4, 2026: 11 items on Sanara MedTech Inc.’s Form 8-K, filed June 9, 2026: 11 without a stated outcome.

Material dissent

None.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2025-2026

Explore Sanara MedTech Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Sanara MedTech Inc.

These tallies are Sanara MedTech Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 9, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Sanara MedTech Inc. — official shareholder meeting results, meeting held June 4, 2026
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Seth D. Yon 5,390,547---- 14,2401,296,806 99.7%Not verified—
Elect Director: Ronald T. Nixon 5,150,750---- 254,0371,296,806 95%Not verified—
Elect Director: Robert A. DeSutter 5,076,342---- 328,4451,296,806 94%Not verified—
Elect Director: Roszell Mack III 5,140,501---- 264,2861,296,806 95%Not verified—
Elect Director: Eric D. Major 5,140,475---- 264,3121,296,806 95%Not verified—
Elect Director: Keith G. Myers 5,295,749---- 109,0381,296,806 98%Not verified—
Elect Director: Sara N. Ortwein 5,152,483---- 252,3041,296,806 95%Not verified—
Elect Director: Ann Beal Salamone 5,133,487---- 271,3001,296,806 95%Not verified—
Elect Director: Eric D. Tanzberger 5,139,360---- 265,4271,296,806 95%Not verified—
2. Ratification of the appointment of Weaver and Tidwell, L.L.P 6,696,0352,1983,360 ---- 99.9%Not verified—
3. Approval, on an advisory basis, of the compensation of the Company's named executive officers 5,280,54657,53066,711 --1,296,806 99%Not verified—

Source: Sanara MedTech Inc., Form 8-K, filed with the SEC on June 9, 2026 — read the filing on EDGAR.

How asset managers voted at the Sanara MedTech Inc. 2025-2026 meeting

Each item below shows how the 88 asset managers that disclosed a Sanara MedTech Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Sanara MedTech Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Elect Director: Ann Beal Salamone

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 5,133,487WITHHELD: 271,300
Details: description as filed, official tally, votes by 29 asset managers

Description as filed by funds: To approve the election of the nine director nominees listed below to serve on the Company's Board of Directors until the 2027 Annual Meeting of Shareholders and until their successors are duly elected and qualified: Ann Beal Salamone

Sanara MedTech Inc.’s own tally for this item (“Elect Director: Ann Beal Salamone”): 5,133,487 for, 271,300 withheld, per its Form 8-K filed June 9, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 95% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 29 asset managers below reported 371,741 for, 1 abstained.

FOR
FOR: 371,741ABSTAIN: 1
Largest asset managers voting on “To approve the election of the nine director nominees listed below to serve on the Company's Board of Director” at Sanara MedTech Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard166,4400 10For
Fidelity76,7530 00For
BlackRock67,3720 00For
TIAA11,6110 00For
Equitable8,2270 00For
Charles Schwab7,4660 00For
Goldman Sachs7,1340 00For
QUANTITATIVE MASTER SERIES LLC5,1910 00For
Northern Trust4,5780 00For
Columbia Threadneedle4,3120 00For
Venerable Variable Insurance Trust2,6530 00For
Lincoln Financial1,9000 00For
Global X1,4780 00For
AIG/SunAmerica1,4660 00For
Pacific Life1,0920 00For
Nationwide6470 00For
Bridge Builder Trust6280 00For
ProShares4670 00For
DWS4350 00For
T. Rowe Price3780 00For
Victory Capital3540 00For
Calvert3130 00For
Principal3100 00For
State Street1690 00For
Morgan Stanley1290 00For

Showing the 25 largest of 29 asset managers. All 29 are in the interactive database (link above).

2. Elect Director: Eric D. Major

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 5,140,475WITHHELD: 264,312
Details: description as filed, official tally, votes by 29 asset managers

Description as filed by funds: To approve the election of the nine director nominees listed below to serve on the Company's Board of Directors until the 2027 Annual Meeting of Shareholders and until their successors are duly elected and qualified: Eric D. Major

Sanara MedTech Inc.’s own tally for this item (“Elect Director: Eric D. Major”): 5,140,475 for, 264,312 withheld, per its Form 8-K filed June 9, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 95% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 29 asset managers below reported 371,428 for, 313 withheld, 1 abstained.

FOR
FOR: 371,428ABSTAIN: 1WITHHOLD: 313
Largest asset managers voting on “To approve the election of the nine director nominees listed below to serve on the Company's Board of Director” at Sanara MedTech Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard166,4400 10For
Fidelity76,7530 00For
BlackRock67,3720 00For
TIAA11,6110 00For
Equitable8,2270 00For
Charles Schwab7,4660 00For
Goldman Sachs7,1340 00For
QUANTITATIVE MASTER SERIES LLC5,1910 00For
Northern Trust4,5780 00For
Columbia Threadneedle4,3120 00For
Venerable Variable Insurance Trust2,6530 00For
Lincoln Financial1,9000 00For
Global X1,4780 00For
AIG/SunAmerica1,4660 00For
Pacific Life1,0920 00For
Nationwide6470 00For
Bridge Builder Trust6280 00For
ProShares4670 00For
DWS4350 00For
T. Rowe Price3780 00For
Victory Capital3540 00For
Calvert00 0313Withhold
Principal3100 00For
State Street1690 00For
Morgan Stanley1290 00For

Showing the 25 largest of 29 asset managers. All 29 are in the interactive database (link above).

3. Elect Director: Eric D. Tanzberger

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 5,139,360WITHHELD: 265,427
Details: description as filed, official tally, votes by 29 asset managers

Description as filed by funds: To approve the election of the nine director nominees listed below to serve on the Company's Board of Directors until the 2027 Annual Meeting of Shareholders and until their successors are duly elected and qualified: Eric D. Tanzberger

Sanara MedTech Inc.’s own tally for this item (“Elect Director: Eric D. Tanzberger”): 5,139,360 for, 265,427 withheld, per its Form 8-K filed June 9, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 95% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 29 asset managers below reported 371,603 for, 139 withheld, 1 abstained.

FOR
FOR: 371,603ABSTAIN: 1WITHHOLD: 139
Largest asset managers voting on “To approve the election of the nine director nominees listed below to serve on the Company's Board of Director” at Sanara MedTech Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard166,3020 1139For
Fidelity76,7530 00For
BlackRock67,3720 00For
TIAA11,6110 00For
Equitable8,2270 00For
Charles Schwab7,4660 00For
Goldman Sachs7,1340 00For
QUANTITATIVE MASTER SERIES LLC5,1910 00For
Northern Trust4,5780 00For
Columbia Threadneedle4,3120 00For
Venerable Variable Insurance Trust2,6530 00For
Lincoln Financial1,9000 00For
Global X1,4780 00For
AIG/SunAmerica1,4660 00For
Pacific Life1,0920 00For
Nationwide6470 00For
Bridge Builder Trust6280 00For
ProShares4670 00For
DWS4350 00For
T. Rowe Price3780 00For
Victory Capital3540 00For
Calvert3130 00For
Principal3100 00For
State Street1690 00For
Morgan Stanley1290 00For

Showing the 25 largest of 29 asset managers. All 29 are in the interactive database (link above).

4. Elect Director: Keith G. Myers

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 5,295,749WITHHELD: 109,038
Details: description as filed, official tally, votes by 29 asset managers

Description as filed by funds: To approve the election of the nine director nominees listed below to serve on the Company's Board of Directors until the 2027 Annual Meeting of Shareholders and until their successors are duly elected and qualified: Keith G. Myers

Sanara MedTech Inc.’s own tally for this item (“Elect Director: Keith G. Myers”): 5,295,749 for, 109,038 withheld, per its Form 8-K filed June 9, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 29 asset managers below reported 371,742 for.

FOR
FOR: 371,742
Largest asset managers voting on “To approve the election of the nine director nominees listed below to serve on the Company's Board of Director” at Sanara MedTech Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard166,4410 00For
Fidelity76,7530 00For
BlackRock67,3720 00For
TIAA11,6110 00For
Equitable8,2270 00For
Charles Schwab7,4660 00For
Goldman Sachs7,1340 00For
QUANTITATIVE MASTER SERIES LLC5,1910 00For
Northern Trust4,5780 00For
Columbia Threadneedle4,3120 00For
Venerable Variable Insurance Trust2,6530 00For
Lincoln Financial1,9000 00For
Global X1,4780 00For
AIG/SunAmerica1,4660 00For
Pacific Life1,0920 00For
Nationwide6470 00For
Bridge Builder Trust6280 00For
ProShares4670 00For
DWS4350 00For
T. Rowe Price3780 00For
Victory Capital3540 00For
Calvert3130 00For
Principal3100 00For
State Street1690 00For
Morgan Stanley1290 00For

Showing the 25 largest of 29 asset managers. All 29 are in the interactive database (link above).

5. Elect Director: Robert A. DeSutter

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 5 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%
FOR: 5,076,342WITHHELD: 328,445
Details: description as filed, official tally, votes by 29 asset managers

Description as filed by funds: To approve the election of the nine director nominees listed below to serve on the Company's Board of Directors until the 2027 Annual Meeting of Shareholders and until their successors are duly elected and qualified: Robert A. DeSutter

Sanara MedTech Inc.’s own tally for this item (“Elect Director: Robert A. DeSutter”): 5,076,342 for, 328,445 withheld, per its Form 8-K filed June 9, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 94% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 29 asset managers below reported 360,670 for, 11,072 withheld, 1 abstained.

FOR
FOR: 360,670ABSTAIN: 1WITHHOLD: 11,072
Largest asset managers voting on “To approve the election of the nine director nominees listed below to serve on the Company's Board of Director” at Sanara MedTech Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard166,3020 1139For
Fidelity76,7530 00For
BlackRock67,3720 00For
TIAA11,6110 00For
Equitable8,2270 00For
Charles Schwab7,4660 00For
Goldman Sachs7,1340 00For
QUANTITATIVE MASTER SERIES LLC5,1910 00For
Northern Trust00 04,578Withhold
Columbia Threadneedle00 04,312Withhold
Venerable Variable Insurance Trust2,4010 0252Mixed
Lincoln Financial1,9000 00For
Global X00 01,478Withhold
AIG/SunAmerica1,4660 00For
Pacific Life1,0920 00For
Nationwide6470 00For
Bridge Builder Trust6280 00For
ProShares4670 00For
DWS4350 00For
T. Rowe Price3780 00For
Victory Capital3540 00For
Calvert00 0313Withhold
Principal3100 00For
State Street1690 00For
Morgan Stanley1290 00For

Showing the 25 largest of 29 asset managers. All 29 are in the interactive database (link above).

6. Elect Director: Ronald T. Nixon

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 5,150,750WITHHELD: 254,037
Details: description as filed, official tally, votes by 29 asset managers

Description as filed by funds: To approve the election of the nine director nominees listed below to serve on the Company's Board of Directors until the 2027 Annual Meeting of Shareholders and until their successors are duly elected and qualified: Ronald T. Nixon

Sanara MedTech Inc.’s own tally for this item (“Elect Director: Ronald T. Nixon”): 5,150,750 for, 254,037 withheld, per its Form 8-K filed June 9, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 95% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 29 asset managers below reported 371,290 for, 452 withheld, 1 abstained.

FOR
FOR: 371,290ABSTAIN: 1WITHHOLD: 452
Largest asset managers voting on “To approve the election of the nine director nominees listed below to serve on the Company's Board of Director” at Sanara MedTech Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard166,3020 1139For
Fidelity76,7530 00For
BlackRock67,3720 00For
TIAA11,6110 00For
Equitable8,2270 00For
Charles Schwab7,4660 00For
Goldman Sachs7,1340 00For
QUANTITATIVE MASTER SERIES LLC5,1910 00For
Northern Trust4,5780 00For
Columbia Threadneedle4,3120 00For
Venerable Variable Insurance Trust2,6530 00For
Lincoln Financial1,9000 00For
Global X1,4780 00For
AIG/SunAmerica1,4660 00For
Pacific Life1,0920 00For
Nationwide6470 00For
Bridge Builder Trust6280 00For
ProShares4670 00For
DWS4350 00For
T. Rowe Price3780 00For
Victory Capital3540 00For
Calvert00 0313Withhold
Principal3100 00For
State Street1690 00For
Morgan Stanley1290 00For

Showing the 25 largest of 29 asset managers. All 29 are in the interactive database (link above).

7. Elect Director: Roszell Mack III

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 5,140,501WITHHELD: 264,286
Details: description as filed, official tally, votes by 29 asset managers

Description as filed by funds: To approve the election of the nine director nominees listed below to serve on the Company's Board of Directors until the 2027 Annual Meeting of Shareholders and until their successors are duly elected and qualified: Roszell Mack III

Sanara MedTech Inc.’s own tally for this item (“Elect Director: Roszell Mack III”): 5,140,501 for, 264,286 withheld, per its Form 8-K filed June 9, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 95% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 29 asset managers below reported 371,741 for, 1 abstained.

FOR
FOR: 371,741ABSTAIN: 1
Largest asset managers voting on “To approve the election of the nine director nominees listed below to serve on the Company's Board of Director” at Sanara MedTech Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard166,4400 10For
Fidelity76,7530 00For
BlackRock67,3720 00For
TIAA11,6110 00For
Equitable8,2270 00For
Charles Schwab7,4660 00For
Goldman Sachs7,1340 00For
QUANTITATIVE MASTER SERIES LLC5,1910 00For
Northern Trust4,5780 00For
Columbia Threadneedle4,3120 00For
Venerable Variable Insurance Trust2,6530 00For
Lincoln Financial1,9000 00For
Global X1,4780 00For
AIG/SunAmerica1,4660 00For
Pacific Life1,0920 00For
Nationwide6470 00For
Bridge Builder Trust6280 00For
ProShares4670 00For
DWS4350 00For
T. Rowe Price3780 00For
Victory Capital3540 00For
Calvert3130 00For
Principal3100 00For
State Street1690 00For
Morgan Stanley1290 00For

Showing the 25 largest of 29 asset managers. All 29 are in the interactive database (link above).

8. Elect Director: Sara N. Ortwein

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 5,152,483WITHHELD: 252,304
Details: description as filed, official tally, votes by 29 asset managers

Description as filed by funds: To approve the election of the nine director nominees listed below to serve on the Company's Board of Directors until the 2027 Annual Meeting of Shareholders and until their successors are duly elected and qualified: Sara N. Ortwein

Sanara MedTech Inc.’s own tally for this item (“Elect Director: Sara N. Ortwein”): 5,152,483 for, 252,304 withheld, per its Form 8-K filed June 9, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 95% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 29 asset managers below reported 371,428 for, 313 withheld, 1 abstained.

FOR
FOR: 371,428ABSTAIN: 1WITHHOLD: 313
Largest asset managers voting on “To approve the election of the nine director nominees listed below to serve on the Company's Board of Director” at Sanara MedTech Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard166,4400 10For
Fidelity76,7530 00For
BlackRock67,3720 00For
TIAA11,6110 00For
Equitable8,2270 00For
Charles Schwab7,4660 00For
Goldman Sachs7,1340 00For
QUANTITATIVE MASTER SERIES LLC5,1910 00For
Northern Trust4,5780 00For
Columbia Threadneedle4,3120 00For
Venerable Variable Insurance Trust2,6530 00For
Lincoln Financial1,9000 00For
Global X1,4780 00For
AIG/SunAmerica1,4660 00For
Pacific Life1,0920 00For
Nationwide6470 00For
Bridge Builder Trust6280 00For
ProShares4670 00For
DWS4350 00For
T. Rowe Price3780 00For
Victory Capital3540 00For
Calvert00 0313Withhold
Principal3100 00For
State Street1690 00For
Morgan Stanley1290 00For

Showing the 25 largest of 29 asset managers. All 29 are in the interactive database (link above).

9. Elect Director: Seth D. Yon

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

99.7% Majority: yes · of votes cast

FOR 99.7%
FOR: 5,390,547WITHHELD: 14,240
Details: description as filed, official tally, votes by 29 asset managers

Description as filed by funds: To approve the election of the nine director nominees listed below to serve on the Company's Board of Directors until the 2027 Annual Meeting of Shareholders and until their successors are duly elected and qualified: Seth D. Yon

Sanara MedTech Inc.’s own tally for this item (“Elect Director: Seth D. Yon”): 5,390,547 for, 14,240 withheld, per its Form 8-K filed June 9, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.7% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 29 asset managers below reported 371,742 for.

FOR
FOR: 371,742
Largest asset managers voting on “To approve the election of the nine director nominees listed below to serve on the Company's Board of Director” at Sanara MedTech Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard166,4410 00For
Fidelity76,7530 00For
BlackRock67,3720 00For
TIAA11,6110 00For
Equitable8,2270 00For
Charles Schwab7,4660 00For
Goldman Sachs7,1340 00For
QUANTITATIVE MASTER SERIES LLC5,1910 00For
Northern Trust4,5780 00For
Columbia Threadneedle4,3120 00For
Venerable Variable Insurance Trust2,6530 00For
Lincoln Financial1,9000 00For
Global X1,4780 00For
AIG/SunAmerica1,4660 00For
Pacific Life1,0920 00For
Nationwide6470 00For
Bridge Builder Trust6280 00For
ProShares4670 00For
DWS4350 00For
T. Rowe Price3780 00For
Victory Capital3540 00For
Calvert3130 00For
Principal3100 00For
State Street1690 00For
Morgan Stanley1290 00For

Showing the 25 largest of 29 asset managers. All 29 are in the interactive database (link above).

10. Approval, on an advisory basis, of the compensation of the Company's named executive officers

Outcome not verifiedFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 5,280,546AGAINST: 57,530
Details: description as filed, official tally, votes by 88 asset managers

Description as filed by funds: TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS, AS DESCRIBED IN THE PROXY STATEMENT.

Sanara MedTech Inc.’s own tally for this item (“3. Approval, on an advisory basis, of the compensation of the Company's named executive officers”): 5,280,546 for, 57,530 against, per its Form 8-K filed June 9, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 29 asset managers voting on “TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS, AS DESCRIBED IN ” at Sanara MedTech Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard166,4410 00For
Fidelity76,7530 00For
BlackRock67,3720 00For
TIAA11,6110 00For
Equitable8,2270 00For
Charles Schwab7,4660 00For
Goldman Sachs7,1340 00For
QUANTITATIVE MASTER SERIES LLC5,1910 00For
Northern Trust4,5780 00For
Columbia Threadneedle4,3120 00For
Venerable Variable Insurance Trust2,6530 00For
Lincoln Financial1,9000 00For
Global X1,4780 00For
AIG/SunAmerica1,4660 00For
Pacific Life1,0920 00For
Nationwide6470 00For
Bridge Builder Trust6280 00For
ProShares4670 00For
DWS4350 00For
T. Rowe Price3780 00For
Victory Capital3540 00For
Calvert3130 00For
Principal3100 00For
State Street1690 00For
Morgan Stanley1290 00For

Fund voting reports, all 29 managers: 371,742 for. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 68 asset managers voting on “TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS, AS DESCRIBED IN ” at Sanara MedTech Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
RBC Capital Markets, LLC116,1480 00For
GEODE CAPITAL MANAGEMENT, LLC85,6620 00For
BlackRock57,2968 00For
T. Rowe Price35,1780 00For
State Street32,4460 00For
Vanguard26,5390 00For
Citadel21,1050 00For
Baird21,0750 00For
MARSHALL WACE, LLP20,3980 00For
SALEM INVESTMENT COUNSELORS INC19,2000 00For
Janney Montgomery Scott LLC17,5300 00For
Northern Trust16,9310 00For
ROCKEFELLER FINANCIAL LLC14,3930 00For
AQR14,1210 00For
Nuveen11,6110 00For
DE Shaw10,9900 00For
MELLON INVESTMENTS Corp09,038 00Against
Charles Schwab7,4660 00For
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM7,1000 00For
Point724,0840 00For
AllianceBernstein3,3000 00For
Sand Hill Global Advisors, LLC2,9730 00For
JACOBS LEVY EQUITY MANAGEMENT, INC2,7390 00For
Goldman Sachs2,5490 00For
NEW YORK STATE COMMON RETIREMENT FUND2,4330 00For

Institutional-manager reports, all 68 managers: 570,081 for, 11,000 against, 602 1 year. Showing the 25 largest; every one is in the interactive database (link above).

11. To approve, on an advisory basis, the frequency of future advisory votes on named executive officer compensation.

No official matchFund totals may overlapSECTION 14A SAY-ON-PAY VOTES

Combines 2 wordings of this item as funds reported it.

100% Fund and manager reports combined; may count the same shares twice · no official result

1 YEAR
Details: description as filed, votes by 88 asset managers

Description as filed by funds: TO APPROVE, ON AN ADVISORY BASIS, THE FREQUENCY OF FUTURE ADVISORY VOTES ON NAMED EXECUTIVE OFFICER COMPENSATION.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 29 asset managers voting on “TO APPROVE, ON AN ADVISORY BASIS, THE FREQUENCY OF FUTURE ADVISORY VOTES ON NAMED EXECUTIVE OFFICER COMPENSATI” at Sanara MedTech Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard00 00--
Fidelity00 00--
BlackRock00 00--
TIAA00 00--
Equitable00 00--
Charles Schwab00 00--
Goldman Sachs00 00--
QUANTITATIVE MASTER SERIES LLC00 00--
Northern Trust00 00--
Columbia Threadneedle00 00--
Venerable Variable Insurance Trust00 00--
Lincoln Financial00 00--
Global X00 00--
AIG/SunAmerica00 00--
Pacific Life00 00--
Nationwide00 00--
Bridge Builder Trust00 00--
ProShares00 00--
DWS00 00--
T. Rowe Price00 00--
Victory Capital00 00--
Calvert00 00--
Principal00 00--
State Street00 00--
Morgan Stanley00 00--

Fund voting reports, all 29 managers: 371,527 1 year, 211 3 year, 5 unknown. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 68 asset managers voting on “TO APPROVE, ON AN ADVISORY BASIS, THE FREQUENCY OF FUTURE ADVISORY VOTES ON NAMED EXECUTIVE OFFICER COMPENSATI” at Sanara MedTech Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
RBC Capital Markets, LLC00 00--
GEODE CAPITAL MANAGEMENT, LLC00 00--
BlackRock00 00--
T. Rowe Price00 00--
State Street00 00--
Vanguard00 00--
Citadel00 00--
Baird00 00--
MARSHALL WACE, LLP00 00--
SALEM INVESTMENT COUNSELORS INC00 00--
Janney Montgomery Scott LLC00 00--
Northern Trust00 00--
ROCKEFELLER FINANCIAL LLC00 00--
AQR00 00--
Nuveen00 00--
DE Shaw00 00--
MELLON INVESTMENTS Corp00 00--
Charles Schwab00 00--
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM00 00--
Point7200 00--
AllianceBernstein00 00--
Sand Hill Global Advisors, LLC00 00--
JACOBS LEVY EQUITY MANAGEMENT, INC00 00--
Goldman Sachs00 00--
NEW YORK STATE COMMON RETIREMENT FUND00 00--

Institutional-manager reports, all 68 managers: 2,947 for, 557,496 1 year, 21,240 3 year. Showing the 25 largest; every one is in the interactive database (link above).

12. Ratification of the appointment of Weaver and Tidwell, L.L.P

Outcome not verifiedAUDIT-RELATEDReported outcome: Not verified

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 6,696,035AGAINST: 2,198
Details: description as filed, official tally, votes by 29 asset managers

Description as filed by funds: TO APPROVE THE RATIFICATION OF THE APPOINTMENT OF WEAVER AND TIDWELL, L.L.P. AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2026.

Sanara MedTech Inc.’s own tally for this item (“2. Ratification of the appointment of Weaver and Tidwell, L.L.P”): 6,696,035 for, 2,198 against, per its Form 8-K filed June 9, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 29 asset managers below reported 371,742 for.

FOR
FOR: 371,742
Largest asset managers voting on “TO APPROVE THE RATIFICATION OF THE APPOINTMENT OF WEAVER AND TIDWELL, L.L.P. AS THE COMPANY'S INDEPENDENT REGI” at Sanara MedTech Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard166,4410 00For
Fidelity76,7530 00For
BlackRock67,3720 00For
TIAA11,6110 00For
Equitable8,2270 00For
Charles Schwab7,4660 00For
Goldman Sachs7,1340 00For
QUANTITATIVE MASTER SERIES LLC5,1910 00For
Northern Trust4,5780 00For
Columbia Threadneedle4,3120 00For
Venerable Variable Insurance Trust2,6530 00For
Lincoln Financial1,9000 00For
Global X1,4780 00For
AIG/SunAmerica1,4660 00For
Pacific Life1,0920 00For
Nationwide6470 00For
Bridge Builder Trust6280 00For
ProShares4670 00For
DWS4350 00For
T. Rowe Price3780 00For
Victory Capital3540 00For
Calvert3130 00For
Principal3100 00For
State Street1690 00For
Morgan Stanley1290 00For

Showing the 25 largest of 29 asset managers. All 29 are in the interactive database (link above).

Largest Sanara MedTech Inc. shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 9,163,969 shares outstanding at the time of that meeting.

Fund voting reports: top Sanara MedTech Inc. shareholders by shares voted on “TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS…”, 2025-2026
#Asset manager % of shares outstanding
1Vanguard 1.82%
2Fidelity 0.84%
3BlackRock 0.74%
4TIAA 0.13%
5Equitable 0.09%
6Charles Schwab 0.08%
7Goldman Sachs 0.08%
8QUANTITATIVE MASTER SERIES LLC 0.06%
9Northern Trust 0.05%
10Columbia Threadneedle 0.05%
Institutional-manager reports: top Sanara MedTech Inc. shareholders by shares voted on “TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS…”, 2025-2026
#Asset manager % of shares outstanding
1RBC Capital Markets, LLC 1.27%
2GEODE CAPITAL MANAGEMENT, LLC 0.93%
3BlackRock 0.63%
4T. Rowe Price 0.38%
5State Street 0.35%
6Vanguard 0.29%
7Citadel 0.23%
8Baird 0.23%
9MARSHALL WACE, LLP 0.22%
10SALEM INVESTMENT COUNSELORS INC 0.21%

Reported Sanara MedTech Inc. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

Sanara MedTech Inc. holdings and ownership disclosed for the 2025-2026 proxy season
Holder % outstanding Disclosure
Ronald T. Nixon 39.02% DEF14A
CGI Cellerate RX, LLC 26.76% DEF14A
FA Sanara, LLC 10.52% DEF14A
S. Oden “Denny” Howell Jr. 5.35% DEF14A
BlackRock 2.50% 13F
Vanguard Group 2.00% 13F
Seth D. Yon 1.24% DEF14A
Geode Capital 0.93% 13F
Renaissance Technologies 0.71% 13F
State Street 0.68% 13F

Percentages above are of 9,163,969 shares outstanding, as reported by Sanara MedTech Inc. on its Form 10-Q dated May 8, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Sanara MedTech Inc.’s 10-Q dated May 8, 2026. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.

Sanara MedTech Inc. proxy season coverage: 2025-2026 (this page).

Cite this page

proxyvotesnow.com, “Sanara MedTech (SMTI) 2026 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/sanara-medtech-inc/2026 (version of November 8, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.